Home/Pipeline/Pain Pipeline

Pain Pipeline

Chronic Pain

Clinical StageActive

Key Facts

Indication

Chronic Pain

Phase

Clinical Stage

Status

Active

Company

Centrexion Therapeutics

About Centrexion Therapeutics

Centrexion Therapeutics is a clinical-stage biotech targeting two high-value, high-unmet-need sectors: non-opioid chronic pain and immunology. The company leverages deep expertise in pain pathophysiology and autoimmune drug development to build a diversified pipeline of novel candidates. With a seasoned leadership team and strategic partnerships with entities like Eli Lilly and Boehringer Ingelheim, Centrexion is positioned to capitalize on growing governmental and private support for non-opioid analgesics and next-generation immunology medicines.

View full company profile

Therapeutic Areas

Chronic Pain Immunology Autoimmune Diseases

Other Chronic Pain Drugs

Drug	Company	Phase	Status
SCI-160	SciSparc	Preclinical	Active
Injectrode Platform for Chronic Pain	Neuronoff	Pre-clinical	Active
Novel PNS System	Nervonik	First-in-Human Completed	Active
High-Definition Spinal Cord Stimulation	Micro-Leads	Unknown	Active
Precision Medicine for Pain	MindX Sciences	Commercial	Active
Chronic Pain Program	Current Surgical	Research	Active
N-19a	Neurocarrus	Pre-clinical	Active
Nav1.7 ASO	Quiver Bioscience	Discovery	Active
Nav1.8 ASO	Quiver Bioscience	Discovery	Active
Dual Nav1.7/1.8 ASO	Quiver Bioscience	Discovery	Active
TMS for Chronic Pain	Magstim	Commercial/Clinical Development	Active
Platform Enhancements	Nevro	R&D	Active